SCHEMBL15517607

SCHEMBL15517607

Cc1ccc2c(c1)C(=O)N(N1CCCCC1)C2=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ CA9 Q16790 3/20 0.43
▸ CA12 O43570 2/20 0.42
▸ CA1 P00915 2/20 0.42
▸ CA2 P00918 1/20 0.41
▸ CHRM2 P08172 1/20 0.40
▸ MAOA P21397 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ TP53 P04637 1/20 0.39
▸ APP P05067 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11706050 0.83 CA9 (0.41) ALDH1A1MAPTL3MBTL1CA9CA12
SCHEMBL10100512 0.77 TERT (0.46) KMT2AALDH1A1MEN1MAPTHSD17B10
SCHEMBL29643230 0.77 ALDH1A1 (0.49) KMT2AALDH1A1MAPTHSD17B10ALOX15
SCHEMBL83222 0.77 ALDH1A1 (0.49) KMT2AALDH1A1MAPTHSD17B10ALOX15
SCHEMBL6193007 0.77 ALDH1A1 (0.49) KMT2AALDH1A1MAPTHSD17B10ALOX15
SCHEMBL1001751 0.75 POLB (0.50) KMT2AALDH1A1MAPTHSD17B10ALOX15
SCHEMBL30595375 0.71 POLB (0.50) KMT2AALDH1A1MAPTHSD17B10ALOX15
SCHEMBL2616778 0.71 APP (0.67) KMT2AALDH1A1MEN1MAPTHSD17B10
SCHEMBL11948126 0.71 ALDH1A1 (0.41) KMT2AALDH1A1MEN1MAPTHSD17B10
SCHEMBL2665475 0.71 MAOA (0.50) ALDH1A1HSD17B10CA9CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2885302-B1 PROCESS FOR THE PREPARATION OF DIPEPTIDYLPEPTIDASE INHIBITORS GLENMARK PHARMACEUTICALS LTD (IN) 2018-03-07 — — EP disclosed
US-9593119-B2 Process for the preparation of dipeptidylpeptidase inhibitors GLENMARK PHARMACEUTICALS LIMITED (IN) 2017-03-14 — — US disclosed
US-20160272642-A1 PROCESS FOR THE PREPARATION OF DIPEPTIDYLPEPTIDASE INHIBITORS GLENMARK LIFE SCIENCES LIMITED (IN) 2016-09-22 — — US disclosed
US-9353114-B2 Process for the preparation of dipeptidylpeptidase inhibitors GLENMARK PHARMACEUTICALS LIMITED (IN) 2016-05-31 — — US disclosed
US-20150239887-A1 PROCESS FOR THE PREPARATION OF DIPEPTIDYLPEPTIDASE INHIBITORS GLENMARK GENERICS LIMITED (IN) 2015-08-27 — — US disclosed
EP-2885302-A2 PROCESS FOR THE PREPARATION OF DIPEPTIDYLPEPTIDASE INHIBITORS Glenmark Pharmaceuticals Limited (IN) 2015-06-24 — — EP disclosed
WO-2014033746-A2 PROCESS FOR THE PREPARATION OF DIPEPTIDYLPEPTIDASE INHIBITORS GLENMARK PHARMACEUTICALS LIMITED; GLENMARK GENERICS LIMITED (IN) 2014-03-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239887-A1 PROCESS FOR THE PREPARATION OF DIPEPTIDYLPEPTIDASE INHIBITORS DPP4, DPP9, DPP3 KMT2A 1054/4885ALDH1A1 590/4885MEN1 4176/4885
US-20160272642-A1 PROCESS FOR THE PREPARATION OF DIPEPTIDYLPEPTIDASE INHIBITORS DPP9, DPP4, DPP7 KMT2A 1189/4885ALDH1A1 681/4885MEN1 3730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback